Related Experiment Video
Updated: Dec 17, 2025

Treatment Protocol for Rotator Cuff Calcific Tendinitis Using a Single-Crystal Piezoelectric Focused Shock Wave Source
Published on: December 23, 2022
Shockwave Intravascular Lithotripsy for the Treatment of Severe Vascular Calcification
George Kassimis1,2, Matthaios Didagelos2, Giovanni Luigi De Maria3
12nd Cardiology Department, Hippokration Hospital, Aristotle University of Thessaloniki, Greece.
Insights
Intravascular lithotripsy (IVL) offers a new approach for treating severely calcified arteries, improving stent placement and patient outcomes. This technology modifies calcium effectively, potentially transforming cardiovascular interventions.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Biomedical Engineering
Background:
- Vascular calcification is common in aging, cardiovascular disease, diabetes, and kidney disease, worsening clinical outcomes.
- Severely calcified lesions impede percutaneous coronary intervention (PCI) with conventional balloons.
- Effective plaque modification is crucial for optimal stent deployment and procedural success.
Purpose of the Study:
- To review current evidence on intravascular lithotripsy (IVL) for treating calcified vascular lesions.
- To highlight optimal patient and lesion selection for IVL application.
- To assess IVL's role in improving stent delivery and long-term outcomes in PCI.
Main Methods:
- Review of existing clinical evidence and data on intravascular lithotripsy technology.
- Analysis of IVL's mechanism of action in modifying arterial calcification.
- Discussion of best practices for patient and lesion selection in IVL procedures.
Main Results:
- Intravascular lithotripsy (IVL) provides circumferential and transmural modification of calcified plaques.
- IVL enhances lesion compliance, facilitating appropriate stent delivery and expansion.
- Evidence suggests IVL improves procedural success and potentially long-term outcomes in complex calcified lesions.
Conclusions:
- Intravascular lithotripsy (IVL) is a promising technology for preparing severely calcified coronary and peripheral arteries.
- Appropriate patient and lesion selection are key to maximizing IVL benefits for stent implantation.
- IVL has the potential to significantly improve outcomes in interventional cardiology, though cost-effectiveness requires further evaluation.
Abstract:
Vascular calcification is a highly prevalent pathophenotype that is associated with aging, atherosclerotic cardiovascular disease, diabetes mellitus, and chronic kidney disease. When present, it portends a worse clinical outcome and predicts major adverse cardiovascular events. Heavily calcified coronary and peripheral artery lesions are difficult to dilate appropriately with conventional balloons during percutaneous intervention, and the use of several adjunctive strategies of plaque modification has been suggested. Intravascular lithotripsy (IVL) offers a novel option for lesion preparation of severely calcified plaques in coronary and peripheral vessels. It is unique among all technologies in its ability to modify calcium circumferentially and transmurally, thus modifying transmural conduit compliance. In this article, we summarize the currently available evidence on this technology, and we highlight its best clinical application through appropriate patient and lesion selection, with the main objective of optimizing stent delivery and implantation, and subsequent improved short- and long-term outcomes. We believe that the IVL balloon will transform the market, as it is easy to use, with predictable results. However, cost-effectiveness of such advanced technology will need to be considered.
Related Concept Videos
Urinary Tract Calculi VI: Surgical Management
Venous Thrombosis III: Interprofessional Care
Urinary Tract Calculi III: Medical Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

